Vaccines that contain certain adjuvants or that trigger stronger local immune responses tend to hurt more both during and after the injection. Among childhood vaccines, the pneumococcal conjugate vaccine (PCV) consistently ranks as one of the more painful shots, while among adult vaccines, COVID-19 and shingles vaccines are well known for producing sore arms that linger for days. But the pain you feel depends on far more than which vaccine is in the syringe. Injection technique, needle choice, your sex, your anxiety level, and what you do in the minutes and hours after the shot all play a role, and most of those factors are things you or your provider can actually control.
Which Vaccines Tend to Hurt More
Head-to-head comparisons are surprisingly rare in the medical literature, because pain is rarely the primary outcome researchers are tracking. But a few well-designed trials give us direct rankings. In a randomized trial of 120 infants receiving two shots at the same visit, the pneumococcal conjugate vaccine (PCV) produced significantly higher pain scores than the combination diphtheria-tetanus-pertussis-Hib vaccine, regardless of which was given first.1JAMA Pediatrics. Order of Vaccine Injection and Infant Pain Response Similarly, when whole-cell pertussis (DTwP) and hepatitis B vaccines were compared in infants, DTwP caused substantially more pain, and giving the less painful hepatitis B shot first reduced the infant’s overall distress across both injections.2PubMed. Effect of change in sequence of administration of DTwP and Hepatitis B vaccines on perception of pain in infants
For adults, the pattern is broadly predictable: vaccines designed to provoke a robust immune reaction tend to produce more arm soreness. The recombinant shingles vaccine (Shingrix), for instance, uses a potent adjuvant system that drives strong immunity but also reliably produces injection-site pain in a large majority of recipients. COVID-19 mRNA vaccines became famous for “vaccine arm,” particularly after the second dose. By contrast, the annual flu shot, which contains no adjuvant in its standard formulation, is usually among the mildest. The practical takeaway from the injection-order studies is worth knowing: if you or your child are getting two shots at the same visit, ask the provider to give the less painful one first. Research consistently shows this lowers total pain across the visit.
Why Some Vaccines Sting More Than Others
The biggest driver of post-injection pain is not the needle itself but the immune storm the vaccine is designed to provoke. Adjuvants, the immune-boosting ingredients added to many vaccines, work by creating a local inflammatory environment at the injection site. They recruit immune cells, trigger the release of signaling molecules, and sometimes form a slow-release depot of antigen under the skin.3PubMed Central. Mechanisms of action of adjuvants All of that inflammation is exactly what makes the vaccine effective, but it is also what makes your arm sore, red, and swollen. Vaccines with stronger or newer adjuvant systems tend to produce more of this local reaction.
The chemical properties of the liquid itself also matter. Solutions with a pH far from neutral or with very high osmolality can irritate tissue.4PubMed Central. Subcutaneous Injection of Drugs: Literature Review of Factors Influencing Pain Sensation at the Injection Site Formulation volume, specific excipients, and the concentration of the active ingredients all contribute to how much discomfort the injection itself causes.5PubMed Central. Understanding and Minimising Injection-Site Pain Following Subcutaneous Administration of Biologics: A Narrative Review Interestingly, though, one factor that people often blame turns out not to matter much: vaccine osmolality. A controlled trial that tested vaccine-like suspensions at different osmolality levels in healthy adults found no relationship between osmolality and burning or pain during injection.6PubMed. Impact of osmolality on burning sensations during and immediately after intramuscular injection of 0.5 ml of vaccine suspensions in healthy adults
Injection Technique Makes a Bigger Difference Than Most People Realize
If you have ever noticed that one nurse’s shots barely register while another’s leave you wincing, you are not imagining things. A randomized trial comparing a fast, no-aspiration injection technique against the traditional slow approach found dramatically different outcomes. Infants in the rapid-injection group had pain scores nearly 40% lower, were roughly half as likely to cry at all, and when they did cry, stopped much faster.7Archives of Disease in Childhood. Vaccine-related pain: randomised controlled trial of two injection techniques The fast technique also cut the actual injection time from about 9 seconds to under 1 second. Current clinical guidelines now recommend this rapid approach for routine intramuscular vaccines.
Needle gauge is another variable providers sometimes debate. Thicker needles (23-gauge) pass through tissue faster and may reduce crying time compared with thinner 25-gauge needles, which take longer to deliver the same volume.8PubMed. Vaccine related reactogenicity for primary immunization: a randomized controlled trial of 23(wider) vs. 25(narrower) gauge needles with same lengths A Cochrane review confirmed a possible slight reduction in pain with wider-gauge needles, though the difference is probably too small to matter in practice.9PubMed Central. Needle size for vaccination procedures in children and adolescents The speed and confidence of the person giving the shot matters far more than the needle they choose.
Does Injection Site Matter
Most adult vaccines go into the deltoid muscle of the upper arm, while infants typically receive shots in the thigh (vastus lateralis). A study of infants given vaccines in each site found similar immediate pain responses but shorter crying duration with the thigh.10PubMed. The pain response of infants in Turkey to vaccination in different injection sites For adults, a randomized trial of outbound travelers found that initial pain on the day of vaccination was similar whether the shot went into the deltoid or the thigh, but by day 7, lingering muscle pain was reported nearly twice as often by those vaccinated in the thigh compared with the deltoid.11PubMed Central. Comparison of levels of satisfaction and rates of adverse events in different anatomical injection sites in outbound travelers So for adults, the deltoid is the better bet for less ongoing soreness, and that is already standard practice for most vaccines.
What You Can Do During the Shot
Several strategies have been tested for reducing pain at the moment of injection, and they work through different mechanisms. The strongest evidence in adults is for topical anesthetics and cooling sprays. A systematic review and meta-analysis found that topical anesthetics like lidocaine cream reduced self-reported pain in adults with a large effect size, while vapocoolant sprays (cold sprays applied just before the needle) also significantly cut acute pain in adults.12PubMed Central. Pharmacological and Combined Interventions to Reduce Vaccine Injection Pain in Children and Adults: Systematic Review and Meta-Analysis The catch with topical anesthetics is that they need to be applied 30 to 60 minutes before the injection, which is not always practical at a busy pharmacy or clinic.
Devices that apply pressure or vibration near the injection site also reduce pain. ShotBlocker, a small plastic device pressed against the skin, reduced pain scores from about 31 mm on a visual analog scale down to 11 mm, performing as well as cold spray.13PubMed Central. Comparison of the efficacy of ShotBlocker and cold spray in reducing intramuscular injection-related pain in adults For children, the Buzzy device, which combines vibration with a cold pack, reduced vaccine injection pain in a randomized trial, likely by flooding the nerves near the injection site with competing sensory signals.14PubMed. The effectiveness of vibratory stimulation in reducing pain in children receiving vaccine injection
Controlled breathing is another free and accessible option. A systematic review found that slow-breathing interventions significantly lowered pain from needle procedures in adults, with a meaningful effect size.15PubMed Central. Simple Psychological Interventions for Reducing Pain From Common Needle Procedures in Adults Simply looking away, on the other hand, and music distraction did not show a clear benefit in the same review. For children, audiovisual distraction, like watching a cartoon on a phone or tablet, has fared better. An observational study found that children watching a screen during vaccination had mean pain scores about a third lower than those with no distraction.16PubMed Central. Audio-Visual Distraction- A Non-Pharmacological Approach to Alleviate Pain in Pediatric Vaccine Administration So the type of distraction matters, and what works for a four-year-old may not work for an adult.
Helping Babies Through Vaccination Pain
Infants cannot take a deep breath on command or watch a distracting video with real comprehension, so different strategies apply. Breastfeeding during or immediately before vaccination is one of the most effective options studied. In a trial comparing breastfeeding, music therapy, and oral sucrose during pentavalent vaccination, infants who breastfed had a median pain score of 4.5 out of 10, compared with 6 for music therapy and 7 for sucrose.17PubMed Central. Comparison of breastfeeding, music therapy, and oral sucrose’s impact on pain relief among infants during pentavalent vaccination The combination of skin-to-skin contact, warmth, and the sweet taste of breast milk appears to activate multiple pain-relief pathways simultaneously.
When breastfeeding is not an option, oral sucrose given a couple of minutes before the injection is a well-established alternative. A randomized controlled trial in infants aged 10 to 18 months found significantly less post-immunization pain in the sucrose group compared with placebo.18PubMed. Efficacy of Sucrose in Reducing Pain during Immunization among 10- to 18-Month-Old Infants and Young Children Sweet taste triggers endogenous opioid release in infants, which is why sugar water is used so widely in neonatal intensive care for minor procedures. Many pediatric offices now offer sucrose routinely before shots, but if yours does not, it is worth asking about.
Managing Soreness After the Shot
The ache that sets in hours after vaccination is a different beast from the needle sting itself. It reflects the local immune response ramping up, and it typically peaks around 24 to 48 hours before fading. Over-the-counter pain relievers like acetaminophen and ibuprofen are the most common treatment, and they work. In a trial of the Oxford/AstraZeneca COVID-19 vaccine, prophylactic acetaminophen cut the odds of pain, muscle ache, and chills roughly in half without affecting the immune response.19npj Vaccines. Use of analgesics/antipyretics in the management of symptoms associated with COVID-19 vaccination
There has been some concern that taking pain relievers around the time of vaccination might blunt your immune response, making the vaccine less effective. A review of the evidence found that observational studies showed no impact on antibody levels, and while a few randomized trials noted slightly lower antibody counts, the effect was only seen after primary vaccination with novel antigens and disappeared after booster doses.20PubMed Central. Effect of antipyretic analgesics on immune responses to vaccination The clinical significance of that temporary dip remains unclear. Most guidance now suggests it is fine to take pain relievers after vaccination if you need them, though taking them preventatively before the shot is less universally recommended for routine vaccines.
Light exercise after vaccination is another approach that has shown promise, though the evidence is mixed. Two randomized trials found that exercising the vaccinated arm reduced reported days of tenderness and swelling.21PubMed. The effect of exercise on local and systemic adverse reactions after vaccinations – Outcomes of two randomized controlled trials A case report on gentle arm exercises after COVID-19 vaccination similarly noted reduced pain and redness.22PubMed Central. Effect of gentle exercises on injection site reaction after Covid-19 vaccination However, another trial found no significant difference in vaccine-related pain with exercise.23PubMed Central. Analgesic and adjuvant properties of exercise with vaccinations in healthy young population Gently moving your arm is unlikely to make things worse, though, and many people find it intuitively helpful for loosening a stiff, sore deltoid.
One Popular Trick That Does Not Work
You may have heard that warming the vaccine vial to body temperature before injection reduces pain. It sounds logical: a cold liquid injected into warm muscle tissue should be more uncomfortable, right? A randomized controlled trial tested this directly with adult diphtheria-tetanus vaccine, comparing warmed vaccine against room-temperature vaccine and a rubbed-at-the-site control. There was no significant difference in pain incidence, pain severity, or peak pain scores between any of the groups at 5 minutes, 24 hours, or 48 hours.24PubMed. Effect of warming adult diphtheria-tetanus vaccine on discomfort after injection The overall incidence of pain was about 56% regardless of preparation method. So warming the vial is one of those practices that persists on intuition rather than evidence.
Women Tend to Report More Pain
Across vaccines and across studies, women consistently report more injection-site pain and more systemic side effects than men. A retrospective study of COVID-19 vaccine recipients found that about 77% of women experienced adverse effects compared with 65% of men, with women reporting higher rates of severe injection-site pain, swelling, redness, nausea, and systemic symptoms.25PubMed Central. COVID-19 vaccination, do women suffer from more side effects than men? A retrospective cross-sectional study This pattern is not unique to COVID-19 vaccines. A review of sex differences across multiple vaccine types, including hepatitis A, hepatitis B, diphtheria-tetanus, pertussis, anthrax, and influenza, found that women reported higher rates of pain across every vaccine studied.26PubMed. Sex differences in injection site reactions with human vaccines
The reasons are almost certainly multiple and layered. Women tend to have stronger immune responses to vaccines in general, which means both better antibody production and more inflammation at the injection site. Hormonal factors, particularly estrogen’s role in modulating immune function, likely contribute. Differences in pain perception and reporting thresholds between the sexes also play a role. Body composition matters too: women generally have less muscle mass in the deltoid, and lower body weight has been identified as a factor that increases susceptibility to injection-site pain.5PubMed Central. Understanding and Minimising Injection-Site Pain Following Subcutaneous Administration of Biologics: A Narrative Review None of this means women are being dramatic. They are genuinely experiencing more inflammation and more nociceptive input from the same vaccine.
When Fear of the Needle Is the Real Problem
For a substantial number of people, the pain of a vaccine is secondary to the dread of the needle itself. Needle phobia is far more common than most healthcare systems acknowledge. Estimates suggest that somewhere between 11.5 million and 66 million adults in the United States may be affected, and many of those people avoid medical care, including vaccination, because of it.27PubMed Central. Considering Needle Phobia among Adult Patients During Mass COVID-19 Vaccinations The wide range in that estimate reflects how underdiagnosed and underreported the condition is. People with needle phobia are not simply nervous; many experience a vasovagal response, with plummeting blood pressure, dizziness, and fainting triggered by the sight or anticipation of a needle.
If you recognize yourself here, a few things can help. Lying down during and for several minutes after the injection reduces the risk of fainting. Applying muscle tension in your legs and abdomen (a technique called applied tension) counteracts the blood-pressure drop. Telling the provider about your phobia is important, because they can adjust their approach: some clinics have private rooms, allow extra time, or have staff trained in distraction techniques. For severe cases, cognitive behavioral therapy has strong evidence for treating needle phobia specifically. And for anyone helping a child develop comfort with medical procedures, how the adults around them react to shots matters enormously. Calm, matter-of-fact framing sets the tone for a child’s long-term relationship with needles.
Microneedle Patches and the Future of Painless Vaccination
The most radical solution to vaccine pain may be eliminating the hypodermic needle entirely. Microneedle patches, which look like small adhesive bandages studded with tiny dissolving projections, deliver vaccine into the top layers of skin where immune cells are densely concentrated. In a Phase 1 clinical trial of a microneedle patch influenza vaccine, 96% of patch recipients reported no pain at all, compared with 82% of those who received the standard intramuscular injection.28BioSupply Trends Quarterly. Study Shows Microneedle Patch Influenza Vaccine Is Effective and Painless Acceptability ratings were slightly higher for the patch groups as well. The tradeoff was more local skin reactions: redness at the application site occurred in about 40% of patch recipients versus none in the injection group, and itching was reported by 82% of patch users compared with 16% in the needle group.
Microneedle technology is still working its way through clinical development for most vaccines, but the appeal is obvious: self-administration at home, no need for trained injectors, no sharps waste, easier storage, and near-zero pain. For the millions of people who delay or skip vaccination because of needle fear, patches could change the equation entirely. The technology also has particular promise for mass-vaccination campaigns in resource-limited settings, where cold-chain logistics and the need for trained healthcare workers are major barriers. Whether itching and redness prove acceptable tradeoffs for the general population remains to be seen as larger trials proceed.